p.72 抽出テキスト

center Registry. Circulation 2017; 135: 2255-2270. PMID: 28341781 133. Ishikawa T, Masuda T, Hachiya T, et al. Brugada syndrome in Japan and Europe: a genome-wide association study reveals shared genetic architecture and new risk loci. Eur Heart J 2024; 45: 2320-2332. PMID: 38747976 134. Porretta AP, Probst V, Bhuiyan ZA, et al. SCN5A overlap syndromes: An open-minded approach. Heart Rhythm 2022; 19: 1363-1368. PMID: 35351625 135. Makimoto H, Nakagawa E, Takaki H, et al. Augmented ST-segment elevation during recovery from exercise predicts cardiac events in patients with Brugada syndrome. J Am Coll Cardiol 2010; 56: 1576- 1584. PMID: 21029874 136. Abe K, Machida T, Sumitomo N, et al. Sodium channelopathy underlying familial sick sinus syndrome with early onset and predominantly male characteristics. Circ Arrhythm Electrophysiol 2014; 7: 511- 517. PMID: 24762805 137. Fatkin D, MacRae C, Sasaki T, et al. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease. N Engl J Med 1999; 341: 1715-1724. PMID: 10580070 138. Arbustini E, Pilotto A, Repetto A, et al. Autosomal dominant dilated cardiomyopathy with atrioventricular block: a lamin A/C defect-related disease. J Am Coll Cardiol 2002; 39: 981-990. PMID: 11897440 139. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010; 121: 1533-1541. PMID: 20172911 140. Wada Y, Ohno S, Aiba T, et al. Unique genetic background and outcome of non-Caucasian Japanese probands with arrhythmogenic right ventricular dysplasia/cardiomyopathy. Mol Genet Genomic Med 2017; 5: 639-651. PMID: 29178656 141. Sawant AC, Bhonsale A, te Riele AS, et al. Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations. J Am Heart Assoc 2014; 3: e001471. PMID: 25516436 142. Saberniak J, Hasselberg NE, Borgquist R, et al. Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. Eur J Heart Fail 2014; 16: 1337-1344. PMID: 25319773 143. James CA, Bhonsale A, Tichnell C, et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol 2013; 62: 1290-1297. PMID: 23871885 144. Ruwald AC, Marcus F, Estes NA 3rd, et al. Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 2015; 36: 1735-1743. PMID: 25896080 145. Gasperetti A, James CA, Cerrone M, et al. Arrhythmogenic right ventricular cardiomyopathy and sports activity: from molecular pathways in diseased hearts to new insights into the athletic heart mimicry. Eur Heart J 2021; 42: 1231-1243. PMID: 33200174 146. Te Riele ASJM, James CA, Sawant AC, et al. Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy in the Pediatric Population: Clinical Characterization and Comparison With Adult-Onset Disease. JACC Clin Electrophysiol 2015; 1: 551-560. PMID: 29759408 147. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med 1988; 318: 129- 133. PMID: 3336399 148. Maron BJ, Udelson JE, Bonow RO, et al. American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology, Council on Cardiovascular Disease in Young, Council on Cardiovascular and Stroke Nursing, et al. Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation 2015; 132: e273-e280. PMID: 26621644 149. Perrin MJ, Angaran P, Laksman Z, et al. Exercise testing in asymptomatic gene carriers exposes a latent electrical substrate of arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2013; 62: 1772-1779. PMID: 23810883 150. Scheel PJ 3rd, Florido R, Hsu S, et al. Safety and Utility of Cardiopulmonary Exercise Testing in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia. J Am Heart Assoc 2020; 9: e013695. PMID: 32009524 151. Imamura T, Sumitomo N, Muraji S, et al. Impact of the T-wave char- acteristics on distinguishing arrhythmogenic right ventricular cardiomyopathy from healthy children. Int J Cardiol 2021; 323: 168-174. PMID: 32877757 152. 日本小児循環器学会.調査報告:CHD・希少疾患サーベイランス

調査結果.https://jspccs.jp/report/database/ 153. Matsuura H, Ichida F, Saji T, et al. Clinical Features of Acute and Fulminant Myocarditis in Children 2nd Nationwide Survey by Japanese Society of Pediatric Cardiology and Cardiac Surgery. Circ J 2016; 80: 2362-2368. PMID: 27725476 154. Vasudeva R, Bhatt P, Lilje C, et al. Trends in Acute Myocarditis Related Pediatric Hospitalizations in the United States, 2007-2016. Am J Cardiol 2021; 149: 95-102. PMID: 33757784 155. Petek BJ, Churchill TW, Moulson N, et al. Sudden Cardiac Death in National Collegiate Athletic Association Athletes: A 20-Year Study. Circulation 2024; 149: 80-90. PMID: 37955565 156. Harris KM, Mackey-Bojack S, Bennett M, et al. Sudden Unexpected Death Due to Myocarditis in Young People, Including Athletes. Am J Cardiol 2021; 143: 131-134. PMID: 33347841 157. 日本循環器学会,日本心不全学会.心筋症診療ガイドライン(2018年改訂版).https://www.j-circ.or.jp/cms/wp-content/uploads/2018/08/ JCS2018_tsutsui_kitaoka.pdf 158. 日本循環器学会.循環器病の診断と治療に関するガイドライン

(2007年度合同研究班報告):心疾患患者の学校,職域,スポーツにおける運動許容条件に関するガイドライン(2008年改訂版). 159. 日本循環器学会.循環器病の診断と治療に関するガイドライン

(2010-2011年度合同研究班報告):小児期心疾患における薬物療法ガイドライン. 160. Lipshultz SE, Orav EJ, Wilkinson JD, et al. Pediatric Cardiomyopathy Registry Study Group. Risk stratification at diagnosis for children with hypertrophic cardiomyopathy: an analysis of data from the Pediatric Cardiomyopathy Registry. Lancet 2013; 382: 1889-1897. PMID: 24011547 161. Morimoto Y, Miyazaki A, Tsuda E, et al. Electrocardiographic changes and long-term prognosis of children diagnosed with hypertrophic cardiomyopathy by the school screening program for heart disease in Japan. J Cardiol 2020; 75: 571-577. PMID: 31836272 162. Jefferies JL, Towbin JA. Dilated cardiomyopathy. Lancet 2010; 375: 752-762. PMID: 20189027 163. Webber SA, Lipshultz SE, Sleeper LA, et al. Pediatric Cardiomyopathy Registry Investigators. Outcomes of restrictive cardiomyopathy in childhood and the influence of phenotype: a report from the Pediatric Cardiomyopathy Registry. Circulation 2012; 126: 1237-1244. PMID: 22843787 164. Rivenes SM, Kearney DL, Smith EO, et al. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation 2000; 102: 876-882. PMID: 10952956 165. Mogensen J, van Tintelen JP, Fokstuen S, et al. The current role of next-generation DNA sequencing in routine care of patients with hereditary cardiovascular conditions: a viewpoint paper of the European Society of Cardiology working group on myocardial and pericardial diseases and members of the European Society of Human Genetics. Eur Heart J 2015; 36: 1367-1370. PMID: 25845928 166. Ishida H, Narita J, Ishii R, et al. Clinical Outcomes and Genetic Analyses of Restrictive Cardiomyopathy in Children. Circ Genom Precis Med 2023; 16: 382-389. PMID: 37377035 167. Mori H, Kogaki S, Ishida H, et al. Outcomes of Restrictive Cardiomyopathy in Japanese Children ― A Retrospective Cohort Study. Circ J 2022; 86: 1943-1949. PMID: 34937816 168. Ichida F. Left ventricular noncompaction Risk stratification and genetic consideration. J Cardiol 2020; 75: 1-9. PMID: 31629663 169. Towbin JA, Lorts A, Jefferies JL. Left ventricular non-compaction cardiomyopathy. Lancet 2015; 386: 813-825. PMID: 25865865 170. Grigoratos C, Barison A, Ivanov A, et al. Meta-Analysis of the Prognostic Role of Late Gadolinium Enhancement and Global Systolic Impairment in Left Ventricular Noncompaction. JACC Cardiovasc Imaging 2019; 12: 2141-2151. PMID: 30878415 171. Hirono K, Hata Y, Miyao N, et al. LVNC study collaborates. Increased Burden of Ion Channel Gene Variants Is Related to Distinct Phenotypes in Pediatric Patients With Left Ventricular Noncompaction. Circ Genom Precis Med 2020; 13: e002940. PMID: 32600061 172. 日本循環器学会.循環器病の診断と治療に関するガイドライン

(2008年度合同研究班報告):急性および慢性心筋炎の診断・治療に関するガイドライン(2009年改訂版). 173. Japanese Circulation Society (JCS) Task Force Committee on Chronic Myocarditis. Guideline for diagnosing chronic myocarditis. Jpn Circ J 1996; 60: 263-264. PMID: 8803719 174. 日本循環器学会.循環器病の診断と治療に関するガイドライン

(2002-2003年度合同研究班報告):急性および慢性心筋炎の診断・治療に関するガイドライン.J Cardiol 2005; 45: 377-384.